The Indian government and the European Union (EU), joined hands for Rs. 240 crore research programme to develop a Next Generation Influenza Vaccine to protect citizens worldwide. Both the EU and the Department of Biotechnology (DBT), Government of India, have also committed EUR 15 million each to fund this joint call for the program named “Horizon 2020”. While the projects require three applicants from both three European member states and India respectively, the call which will remain open until April 16, 2019, also allows applicants from other countries to join the EU-India consortia. The first information event which was held in New Delhi saw 100 applicants both from India and Europe taking part in it.